Multicenter study for maternal serum triple markers to establish Japanese standards: Maternal serum marker study group, Japan Association of Prenatal Diagnostics

Acta Obstetrica et Gynaecologica Japonica

Volumn 51, Issue 11, 1999, Pages 1042-1048

  Miyamura, Tsunetake ^a   Saito, Nakamiti ^a   Touno, Atsuhiko ^a   Nagata, Shin ^a   Hidaki, Tsutomu ^a   Ishimaru, Tadayuki ^a   Masuzaki, Hideaki ^a   Ohama, Koso ^a   Miharu, Norio ^a   Hisanaga, Sachio ^a   Suenaga, Goro ^a   Suenaga, Toshiro ^a   Hatae, Masayuki ^a   Kamitomo, Masato ^a   Fuse, Masaki ^a   Hirai, Masanao ^a  

^a NONE

Author keywords

fetoprotein; Free human chorionic gonadotropin; Japanese; Trisomy 21; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL;

ADULT; AGE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL DIAGNOSIS; SECOND TRIMESTER PREGNANCY; STANDARD; TRISOMY 21;

EID: 0032692440     PISSN: 03009165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Merkatz IR, Nitwsky HM, Marci JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984 ; 148 : 886-894
2. Doran TA, Cadesky K, Wong PY, Mastrogiacomo C, Capello T. Maternal serum α-fetoprotein and fetal autosomal trisomies. Am J Obstet Gynecol 1986 ; 154 : 277-281
3. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Combining maternal serum α-fetoprotein measurements and age to screen for Down Syndrome in pregnant women under age 35. Am J Obstet Gynecol 1989 ; 160 : 575-581
4. Kronquist KE, Dreazen E, Keener SL, Nicholas TW, Crandall BF. Reduced fetal hepatic alpha-fetoprotein levels in Down's syndrome. Prenant Diagn 1990 ; 10 : 739-751
5. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987 ; 7 : 623-630
6. Petrocik E, Wassman ER, Kelly JC . Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels. Am J Obstet Gynecol 1989 ; 161 : 1168-1173
7. Spencer K. Evaluation of an assay of the free β-subunit of choriogonadotropin and its potential value in screening for Down's syndrome 1. Clin Chem 1991 ; 37 : 809-814
8. Bogart MH, Jones OW, Felder RA, Best RG, Bradley L, Buts W, Crandall B, MacMahon W, Frank H, Wians J, Loeh PV. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991 ; 165 : 663-667
9. Spencer K, Marci JN. The use of free β-hCG in antenatal screening for Down's syndrome. Br J Obstet Gynaecol 1994 ; 101 : 175-181
10. Knight GJ, Palomaki GE, Neveux LM, Fodor KK, Haddow JE. hCG and the free β-subunit as screening tests for Down syndrome. Prenat Diagn 1998 ; 18 : 235-245
11. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 1988 ; 95 : 303-333
12. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, Knight GJ, Palomaki GE. Maternal serum unconjugated oestriol as an ant enatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988 ; 95 : 334-341
13. Ryall RG, Staples AJ, Robertson EF, Pollard AC. Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses. Prenat Diagn 1992 ; 12 : 251-261
14. Wald NJ, Densem JW, Smith D, Klee GG. Four-Marker serum screening for Down's syndrome. Prenat Diagn 1994 ; 11 : 707-716
15. Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, Bombard A. Triple marker (α-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus α-fetoprotein plus free-β subunit in second-trimester maternal serum screening for fetal Down syndrome : A prospective comparison study. Am J Obstet Gynecol 1995 ; 173 : 1306-1309
16. Muller F, Bussières L, Pèlissier M-C, Oury J-F, Boué C, Uzan S, Boué A. Doracial differences exist in second-trimester maternal hCH levels? A study of 23369 patients. Prenat Diagn 1994 ; 14 : 633-636
17. Onda T, Kitagawa M, Takeda O, Sago H, Kubonoya K, Iinuma K, Bradley LA, Canick JA, Krasikov NE, Ponting NR, Grier RE. Triple marker screening in native Japanese women. Prenat Diagn 1996 ; 16 : 713-717